Dimethyl Fumarate-Induced Takotsubo Cardiomyopathy in a Patient With Relapsing-Remitting Multiple Sclerosis

Dimethyl fumarate (DMF) is an approved oral pharmacologic agent used in the treatment of relapsing-remitting multiple sclerosis (RRMS). Although commonly used in clinical practice, its mechanism of action remains largely unknown. Some frequent side effects associated with this drug are angioedema, h...

Descripción completa

Detalles Bibliográficos
Autor principal: Srichawla, Bahadar S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067331/
https://www.ncbi.nlm.nih.gov/pubmed/35518534
http://dx.doi.org/10.7759/cureus.23789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067331/
https://www.ncbi.nlm.nih.gov/pubmed/35518534
http://dx.doi.org/10.7759/cureus.23789

Ejemplares similares